Does Pafolacianine Injection Interact with Folate Multivitamin?
CDI records a major classification for Pafolacianine Injection and Folate Multivitamin. The stored summary is: Folate may reduce binding of pafolacianine to folate receptors and could reduce detection of lesions. Avoid administration within 48 hours before CYTALUX. The mechanism involves reduced binding to folate receptors. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Folate Multivitamin Class
- Vitamin D
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Reduced binding to folate receptors
What To Tell Your Doctor or Pharmacist
If you are taking Pafolacianine Injection and your doctor is considering prescribing Folate Multivitamin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider